
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1041 | 997 | 996 | 1229 | 1597 | 2164 |
Fund Return | 4.06% | -0.34% | -0.38% | 7.12% | 9.82% | 8.02% |
Place in category | 570 | 544 | 577 | 96 | 51 | 115 |
% in Category | 63 | 65 | 65 | 16 | 11 | 37 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AXA Framlington Global Technology a | 1.09B | -4.99 | 7.63 | 17.40 | ||
AXA Framlington Global Technology F | 1.09B | -4.99 | 7.63 | 17.40 | ||
GB00B5LXGG05 | 1.04B | -3.24 | 12.67 | 15.55 | ||
AXA Global Distribution R Acc | 254.94M | 5.74 | -1.26 | 4.97 | ||
AXA Global Distribution R Inc | 254.94M | 7.05 | -0.84 | 5.18 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Global Life Sciences Fund U G | 3.92B | 5.15 | 9.71 | 9.90 | ||
Wellington Global Health Care EquiG | 1.91B | 6.70 | 4.03 | 11.14 | ||
Adamant Medtech I GBP | 1.52B | 7.47 | 6.21 | 12.34 | ||
Global Health Care Fund W Acc GBP | 102.9M | 7.87 | 5.51 | 9.11 | ||
Pharmaceuticals Index Trust I Acc | 489.73M | 3.24 | 1.99 | 9.39 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.67 | 837.57 | -0.59% | |
Merck&Co | US58933Y1055 | 4.98 | 93.11 | -1.71% | |
Thermo Fisher Scientific | US8835561023 | 4.98 | 517.72 | -0.18% | |
UnitedHealth | US91324P1021 | 4.87 | 516.85 | +1.09% | |
Novo Nordisk B | DK0062498333 | 4.83 | 528.8 | -2.85% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Neutral |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review